why choose us

First received: August 23, 2022

Clinical Trial: Thyroid Hormone for Treatment of Nonalcoholic Steatohepatitis in Veterans

Study Status: Completed

Recruit Status: RECRUITING

Condition: Nonalcoholic Steatohepatitis

Study Type: INTERVENTIONAL


Official Title: Low Dose Thyroid Hormone, Mitochondrial Fatty Acid Oxidation, and Treatment of Nonalcoholic Steatohepatitis (NASH)

Brief Summary: Nonalcoholic steatohepatitis (NASH) is the aggressive form of nonalcoholic fatty liver disease, which is rapidly becoming a worldwide public health problem.It is more common in the military and Veteran population compared to the general US population.NASH may progress to end-stage liver disease and primary liver cancer, and hence there is critical need for effective treatment.The goal of this clinical trial is to test whether low dose thyroid hormone administered to Veterans diagnosed with NASH can be an effective…

Read more